No way today or this week, I don't expect to see $3 before next month. Upcoming catalysts for MEIP. Four Catalysts are stacked up in a row beginning May 21.
1. AML 6 month phase 2 trial data on all 50 patients, Abstract on -line May 21, presentation at EHA June 11-14 where there may be further update. Plans to begin pivotal P3 AML trial in JUN15
2. Phase 2 refractory MDS data expected July- Aug 2015
3. ME-344 (mitochondrial inhibitor IV anti-cancer agent)--P1B Trial, ClinicalTrials.gov ID NCT02100007 w/ results expected mid-2015 (2-3Q15 estimate) for open-label P1B trial in combination w/ HYCAMTIN (topotecan) for treatment of small cell lung & ovarian cancers. In OCT14 dosed first pt in cohort expansion stage of trial
4. PWT143: PI3K delta inhibitor anti-cancer agent which is expected to begin clinical trials during 1H15
6. Complete MDS data phase 2 in DEC 2014
News 
Market Data 
Discover 
